Savion M, Wolloch Y, Savir A
Department of Urology, Beilinson Medical Center, Petah Tikva, Israei.
J Urol. 1989 Dec;142(6):1500-1. doi: 10.1016/s0022-5347(17)39138-3.
Sclerotherapy with 2.5% phenol solution was used to treat 63 hydroceles in 55 patients with a mean age of 69 years. In 51.6% of the patients (32 hydroceles) 1 treatment was sufficient, while 2 treatments were necessary in 25.8% (16 hydroceles), 3 in 13% (8 hydroceles) and 4 in 8% (5 hydroceles). One patient required 7 injections. Treatment was unsuccessful in 1 patient in whom a local allergic reaction developed. Only 1 patient complained of pain, and other complications were rare and mild. On the basis of this experience we concluded that sclerotherapy with phenol 2.5% is a painless, highly effective, safe and economical procedure that permits one to avoid an operation, anesthesia and hospitalization. Its use is warranted in adults and particularly in the elderly.
采用2.5%苯酚溶液硬化疗法治疗55例平均年龄69岁患者的63例鞘膜积液。51.6%的患者（32例鞘膜积液）单次治疗即足够，25.8%（16例鞘膜积液）需2次治疗，13%（8例鞘膜积液）需3次治疗，8%（5例鞘膜积液）需4次治疗。1例患者需要7次注射。1例患者出现局部过敏反应，治疗失败。仅1例患者抱怨疼痛，其他并发症罕见且轻微。基于该经验，我们得出结论，2.5%苯酚硬化疗法是一种无痛、高效、安全且经济的方法，可避免手术、麻醉和住院。该方法适用于成年人，尤其适用于老年人。
